Immunization Service Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Obstet Gynecol. 2023 Mar 1;141(3):563-569. doi: 10.1097/AOG.0000000000005101. Epub 2023 Jan 16.
To examine the association between influenza vaccination during pregnancy and infant influenza vaccination.
We conducted a retrospective analysis of individuals aged 15-49 years who were continually privately insured from August 2017 to May 2019 and had singleton live births between September 2017 and February 2018 and their infants. Influenza vaccination coverage was assessed for pregnant people during the 2017-2018 influenza season and for their infants during the 2018-2019 season using the 2017-2019 MarketScan data. Multivariate log-binomial regressions were conducted to examine the association between influenza vaccination during pregnancy and infant influenza vaccination.
Of the 34,919 pregnant people in this analysis, 14,168 (40.6%) received influenza vaccination during pregnancy. Of the infants born to people vaccinated during pregnancy, 90.0% received at least one dose of influenza vaccine during the 2018-2019 season and 75.5% received at least two doses. Of the infants born to those not vaccinated during pregnancy, 66.3% received at least one dose of influenza vaccine and 51.8% received at least two doses. At-least-one-dose coverage was 35.7% higher (adjusted risk ratio [aRR] 1.34, 95% CI 1.33-1.36) and at-least-two-dose coverage was 45.8% higher (aRR 1.43, 95% CI 1.41-1.46) for infants born to people who received influenza vaccination during pregnancy compared with infants born to people who did not.
Our results show a positive and statistically significant relationship between influenza vaccination during pregnancy and infant influenza vaccination status in their first season eligible for vaccination. Interventions to increase influenza vaccination coverage among pregnant people may also increase infant influenza vaccination coverage, offering greater protection against serious complications of influenza in both vulnerable populations.
研究孕妇流感疫苗接种与婴儿流感疫苗接种的关系。
我们对 2017 年 8 月至 2019 年 5 月期间持续私人投保、2017 年 9 月至 2018 年 2 月期间分娩单胎活产儿的 15-49 岁个体进行了回顾性分析。利用 2017-2019 年 MarketScan 数据,评估了 2017-2018 年流感季孕妇流感疫苗接种率和 2018-2019 年流感季婴儿流感疫苗接种率。采用多变量二项式回归分析孕妇流感疫苗接种与婴儿流感疫苗接种的关系。
在这项分析中,34919 名孕妇中,14168 人(40.6%)在孕期接种了流感疫苗。在孕妇接种疫苗所生婴儿中,90.0%在 2018-2019 年接种了至少一剂流感疫苗,75.5%接种了至少两剂。在未在孕期接种疫苗的孕妇所生婴儿中,66.3%接种了至少一剂流感疫苗,51.8%接种了至少两剂。与未在孕期接种疫苗的孕妇所生婴儿相比,接种疫苗孕妇所生婴儿至少一剂疫苗接种覆盖率高 35.7%(调整风险比[aRR]1.34,95%置信区间[CI]1.33-1.36),至少两剂疫苗接种覆盖率高 45.8%(aRR 1.43,95%CI 1.41-1.46)。
本研究结果表明,孕妇流感疫苗接种与婴儿在可接种疫苗的首个流感季的流感疫苗接种状况呈正相关,且具有统计学意义。增加孕妇流感疫苗接种覆盖率的干预措施也可能增加婴儿流感疫苗接种覆盖率,为这两个脆弱人群提供对流感严重并发症的更大保护。